Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Tian Pei Hong"'
Publikováno v:
European Journal of Medical Research, Vol 26, Iss 1, Pp 1-11 (2021)
Abstract Background The purpose of present study was to explore the mechanism of nuclear factor-kappa B (NF-κB), phosphatidylinositol 3-kinase (PI3K)/protein kinase B(PKB/Akt) and mitogen-activated protein kinase (MAPK) signaling pathways after inte
Externí odkaz:
https://doaj.org/article/002bac8597e84da4988f76435f4b35bb
Autor:
Hui Yu, Li-Fang Xie, Kang Chen, Gang-Yi Yang, Xiao-Yan Xing, Jia-Jun Zhao, Tian-Pei Hong, Zhong-Yan Shan, Hong-Mei Li, Bing Chen, Xu-Lei Tang, Ling Qi, Jing Yang, Yuan Fang, Ting Li, Shuang-Shuang Wang, Xue Liang, Ya-Qi Yin, Yi-Ming Mu
Publikováno v:
Chinese Medical Journal, Vol 129, Iss 7, Pp 778-784 (2016)
Background: Type 2 diabetes mellitus (T2DM) has traditionally been considered to affect mainly the elderly; however, the age at diagnosis has gradually reduced in recent years. Although the incidence of young-onset T2DM is increasing, it is still not
Externí odkaz:
https://doaj.org/article/ef5341930a504898be7ec53e0c137775
Autor:
Xiao-Ling Cai, Ying-Li Chen, Jia-Jun Zhao, Zhong-Yan Shan, Ming-Cai Qiu, Cheng-Jiang Li, Wei Gu, Hao-Ming Tian, Hua-Zhang Yang, Yao-Ming Xue, Jin-Kui Yang, Tian-Pei Hong, Li-Nong Ji
Publikováno v:
Chinese Medical Journal, Vol 128, Iss 10, Pp 1279-1287 (2015)
Background: At present, China has listed the compound tablet containing a fixed dose of rosiglitazone and metformin, Avandamet, which may improve patient compliance. The aim of this study was to evaluate the efficacy and safety of Avandamet or uptitr
Externí odkaz:
https://doaj.org/article/be1ad40dca8e49378989f34444c6d91d
Publikováno v:
European Journal of Medical Research, Vol 26, Iss 1, Pp 1-11 (2021)
European Journal of Medical Research
European Journal of Medical Research
Background The purpose of present study was to explore the mechanism of nuclear factor-kappa B (NF-κB), phosphatidylinositol 3-kinase (PI3K)/protein kinase B(PKB/Akt) and mitogen-activated protein kinase (MAPK) signaling pathways after intervention
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0981aa8109a772545a85d9a8f7e271
https://doaj.org/article/002bac8597e84da4988f76435f4b35bb
https://doaj.org/article/002bac8597e84da4988f76435f4b35bb
Autor:
Wen-hua Xiao, Yan-rong Wang, Wen-fang Hou, Chao Xie, Hai-ning Wang, Tian-pei Hong, Hong-wei Gao
Publikováno v:
International Journal of Endocrinology, Vol 2013 (2013)
Aim. To investigate whether pioglitazone had detrimental effects on biochemical markers of bone turnover in patients with type 2 diabetes (T2DM). Methods. Seventy patients with T2DM were included in this study. The patients remained on their previous
Externí odkaz:
https://doaj.org/article/c958e2d350c841fbbfd1f35cf42926c9
Autor:
Shu-jing Zhou, Fang Chen, Tian-pei Hong, Hui-xian Yan, Lin Jiang, Hong-xin Jin, Wei Huang, Wen-cheng An, Bo An, Xiao-hong Ou, Xue-pei Xia, Yue Pan, Jing Jin, Zhao-hui Lyu, Zhi-jun Cui
Publikováno v:
Bioscience Reports
Graves’ disease (GD) occurs due to an autoimmune dysfunction of thyroid gland cells, leading to manifestations consistent with hyperthyroidism. Various studies have confirmed the link between autoimmune conditions and changes in the composition of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4c9f01beac25c17a6f293645306f0c
https://doi.org/10.1042/bsr20191242
https://doi.org/10.1042/bsr20191242
Autor:
Hui-xian Yan, Wen-cheng An, Fang Chen, Bo An, Yue Pan, Jing Jin, Xue-pei Xia, Zhi-jun Cui, Lin Jiang, Shu-jing Zhou, Hong-xin Jin, Xiao-hong Ou, Wei Huang, Tian-pei Hong, Zhao-hui Lyu
Publikováno v:
Bioscience Reports; Sep2020, Vol. 40 Issue 9, p1-11, 11p
Autor:
Tian-pei, Hong, Rui, Wei
Publikováno v:
Zhonghua yi xue za zhi. 93(36)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40ac80b4a99a96d2e4438e579e041d06
https://pubmed.ncbi.nlm.nih.gov/24373393
https://pubmed.ncbi.nlm.nih.gov/24373393
Publikováno v:
World journal of gastroenterology. 20(27)
Glucagon-like peptide-1 (GLP-1)-based therapies have demonstrated efficacy and safety in treating type 2 diabetes, which shares a similar pathophysiological mechanism with non-alcoholic fatty liver disease (NAFLD). Recent studies showed that glucose-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dfcfd3e39dc67751c8b5af0b20f69d99
https://pubmed.ncbi.nlm.nih.gov/25083081
https://pubmed.ncbi.nlm.nih.gov/25083081
Autor:
Yuanyuan, Chen, Ruopeng, Feng, Hong, Wang, Rui, Wei, Jin, Yang, Liang, Wang, Haining, Wang, Lin, Zhang, Tian-pei, Hong, Jinhua, Wen
Publikováno v:
Diabetes/metabolism research and reviews. 30(6)
Type 2 diabetes is caused by interactions between genetic and environmental factors. Our previous studies reported that paired box 6 mutation heterozygosity (Pax6(m/+)) led to defective proinsulin processing and subsequent abnormal glucose metabolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0d74e7df89d44a156e1e662b2e2c1489
https://pubmed.ncbi.nlm.nih.gov/24925705
https://pubmed.ncbi.nlm.nih.gov/24925705